Kathy Lee-Sepsick, President & CEO at Femasyshttps://www.femasys.com/Latest in HomeSponsoredWhy Biocompatibility Plans Should Focus on Storytelling, Not Data DumpingApril 9, 2026RadNet Acquires ONRAD's Radiology Professional Services PlatformOctober 27, 2026Abbott Launches Whole-Genome Sequencing Molecular Residual Disease TestOctober 27, 2026Cybersecurity Issue Forces Major New Mexico Hospital to Divert Patients, Close ClinicsOctober 27, 2026Related StoriesHomeDemand Generation vs. Lead Generation vs. Account-Based Marketing: Which is Best for Medical Manufacturing?HomeBiotricity Announces Inclusion as a Supplier to A Prominent Medical System That Services 21 StatesSurgicalMelzi, Spartan Medical Partner to Reduce Surgical Sharps MiscountsSponsor ContentWhy Biocompatibility Plans Should Focus on Storytelling, Not Data Dumping
